Published April, 2012
By Rainer Haas, Ralf Kronenwett and Georg Sczakiel
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Recent Results in Cancer Research
Rating:
Availability: Not available (reason unspecified)

---

Published March, 2012
By Pavel Koldovsky
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Recent Results in Cancer Research
Rating:
Availability: Not available (reason unspecified)

---

Published March, 2012
By Enrico Anglesio
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Recent Results in Cancer Research
Rating:
Availability: Not available (reason unspecified)

The discussion of some diseases is only occasionally enlivened by the emergence of new worthwhile facts.

---

Published March, 2012
By P. Bannasch, A. Schimpl and Peter Bannasch
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Recent Results in Cancer Research
Rating:
Availability: Not available (reason unspecified)

Used in the proper dose, these carcinogens lead within a few months to the formation of multicentric hepatomas in practically 100 Ufo of the experimental animals, and are therefore a very useful tool for studies of the cytogenesis of cancer (see BUCHNER, 1961;

---

Published March, 2012
By Georges Mathe and Maurice Schumann
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Recent Results in Cancer Research
Rating:
Availability: Not available (reason unspecified)

The European Organization for Research into Cancer Treatment (OERTC), founded in 1962 initially under the name Groupe Europeen de Chimiotherapie Anti cancereuse (GECA), is an extramural European Institute for collecting, co-ordinating and encouraging the work of scientists researching into cancer treatment at 16 European institutes: 3 in W.

---

Published March, 2012
By Hans-Jorg Senn, Beat Thurlimann, Aron Goldhirsch, Richard D. Gelber and Hans-Joerg Senn
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Recent Results in Cancer Research
Rating:
Availability: Not available (reason unspecified)

This RRCR-conference-volume marks "number six" in a 20-year evolution of international conferences on the adjuvant therapy of primary breast cancer.

---

Published March, 2012
By J.E. Ultmann, M.L. Griem, W.H. Kirsten and R.W. Wissler
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Recent Results in Cancer Research
Rating:
Availability: Not available (reason unspecified)

Symposium, The University of Chicago Pritzker School of Medicine, March 7th and 8th, 1970

---

Published March, 2012
By James H. Goldie, Joseph Ragaz, Pierre Band and Pierre R. Band
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Recent Results in Cancer Research
Rating:
Availability: Not available (reason unspecified)

Despite recent advances in adjuvant therapies of cancer, the regi mens of postoperative adjuvant chemotherapy treatment which are presently available fail to cure the majority of cancer patients. For the first time, clinicians have a chance to follow the in vivo response of the tumor exposed to preoperative chemotherapy.

---

Published March, 2012
By Siegfried Seeber
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Recent Results in Cancer Research
Rating:
Availability: Not available (reason unspecified)

---

Published March, 2012
By Donald Metcalf and Macfarlane Burnet
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Recent Results in Cancer Research
Rating:
Availability: Not available (reason unspecified)

The sudden burst of interest in the thymus during the last five years more than justifies the appearance of a monograph on those aspects of its function which bear particularly on immunity and the processes associated with the development of malignant disease.

---